Sign in

CIK 0000320017 · Non-accelerated filer<br>Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
222343568
Phone
908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations · Regulation FD disclosure
  3. 4 Shares withheld for taxes EVP, R&D and CMO gave up 2,908 shares (to pay taxes)
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations · Regulation FD disclosure
  6. S-8 Other Securities Offered to Employees in Benefit Plans
  7. 8-K Event Executive or director change
  8. 8-K Event Shareholder vote results
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations · Regulation FD disclosure
  11. DEFA14A Proxy Proxy Materials
  12. DEF 14A Proxy Proxy Statement
  13. 8-K Event Executive or director change
  14. 10-K Report Annual Report
  15. 8-K Event Results of operations · Regulation FD disclosure
  16. 8-K Event Results of operations · Regulation FD disclosure · Other events
  17. 4 Shares withheld for taxes Chief Executive Officer gave up 397 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Executive Officer gave up 1,030 shares (to pay taxes)
  19. 4 Grant or award Director acquired 20,000 shares (grant or award)
  20. 4 Grant or award Director acquired 20,000 shares (grant or award)

Page 7 of 80 · 1,583 filings